De novoinduction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors

Ganss and colleagues show that targeting the inflammatory cytokine LIGHT to tumor vessels via a vascular targeting peptide induces tertiary lymphoid structures and enables the influx of endogenous T cells and tumor killing.